Kara Fitzgerald, ND, received her doctor of naturopathic medicine degree from the National University of Natural Medicine in Portland, Oregon. She completed the first Counsel on Naturopathic Medicine-accredited post-doctorate position in nutritional biochemistry and laboratory science at Metametrix Clinical Laboratory under the direction of Richard Lord, PhD. Her residency was completed at Progressive Medical Center, a large, integrative medical practice in Atlanta, Georgia. Dr. Fitzgerald is the lead author and editor of Case Studies in Integrative and Functional Medicine and is a contributing author to Laboratory Evaluations for Integrative and Functional Medicine and the Institute for Functional Medicine (IFM)’s Textbook for Functional Medicine. With the Helfgott Research Institute, Dr. Fitzgerald is actively engaged in clinical research on the DNA methylome using a diet and lifestyle intervention developed in her practice. The first publication from the study focuses on reversal of biological aging and was published 04-12-2021 in the journal Aging. She has published a consumer book titled Younger You as well as a companion cookbook, Better Broths and Healing Tonics and has an application-based Younger You Program, based on the study. Dr. Fitzgerald is on the faculty at IFM, is an IFM Certified Practitioner and lectures globally on functional medicine. She runs a Functional Nutrition Residency program, and maintains a podcast series, New Frontiers in Functional Medicine and an active blog on her website, www.drkarafitzgerald.com. Her clinical practice is in Sandy Hook, Connecticut. Additional publications

covid-cold

Two Mechanisms Potentially Improving Acquired Immunity to COVID-19: The Common Cold and Breastmilk

People who have been exposed to a seasonal “common cold” may experience less severe COVID-19 symptoms. While we’ve discussed this topic previously, a study from the Journal of Clinical Investigation reports the first clinical evidence of cross reactivity with the common cold and COVID. This is due to previous immune responses against the four endemic…

Episode 69: Sponsored | Telomere Integrity: What Clinicians Need to Know with Dr. Joseph Raffaele

Sponsored |The Best Biomarker of Aging: What Clinicians Need to Know

I am particularly fascinated by new advances in testing biological age and how these biomarkers relate to disease risk. My podcast guest today is Dr. Joseph Raffaele MD, a leading expert, researcher, and clinician on the topic of biological aging and telomeres. We talked last year on New Frontiers, and I’m psyched to continue the conversation!

This time, Dr. Raffaele and I explore the various tests he uses to determine physiological age and disease risk, and go big into how senescent T cells and infections, such as cytomegalovirus, increase COVID-19 risk, particularly in a younger, seemingly healthy population. You’re going to love this enticing convo on the role of aging as it relates to disease and COVID-19 risk, and might find some great take-away clinical pearls to use in your own practice. Settle in, this is a good one, and let me know what you think by leaving a review or comment! ~DrKF

Dr. Patrick Hanaway podcast cover

Stage IV Cancer: Dr. Patrick Hanaway’s Personal Experience with Functional & Integrative Modalities

Is it fair that I say – yet again – that this was my best conversation this year? My most deeply personal, honest, heartfelt, love-filled, scientific, evidence-informed (and pearl-ladened) conversation on cancer and recovery? Well, Dr. Patrick Hanaway, MD is a mentor, a colleague, a friend, and an amazing guy. His journey as a leader in functional medicine through stage IV laryngeal cancer and his embrace of a metabolic approach was profound.

weight-loss

Medications May Undermine Weight Loss Efforts in Diabetics

New research adds to our existing knowledge and experience that some medications may inhibit weight loss, even when lifestyle interventions such as diet and exercise are prioritized. The Look AHEAD randomized study followed over 5000 middle-aged diabetic participants for 13.5 years and found overweight or obese participants taking obesogenic medications, or drugs that tend to…